oral cancer

Raising awareness about HPV-linked oropharyngeal cancer
Raising awareness about HPV-linked oropharyngeal cancerWhy hygienists must be diligent in screening new and established patients.
Can ill-fitting dentures increase your oral cancer risk?
Can ill-fitting dentures increase your oral cancer risk?Researchers in India have determined that dentures that fit improperly can be a risk factor for developing oral cancer.
Can ill-fitting dentures increase your oral cancer risk?
Can ill-fitting dentures increase your oral cancer risk?Researchers in India have determined that dentures that fit improperly can be a risk factor for developing oral cancer.
Using detection tools to prevent oral cancer: A product roundupDentists are the front line of defense when it comes to detecting oral cancer.
Using detection tools to prevent oral cancer: A product roundup
The top 10 dental discoveries of 2016We take a look at some of the most interesting and engaging dental studies and discoveries from 2016.
Why educating the entire team in oral cancer detection protocol is critical
Why educating the entire team in oral cancer detection protocol is criticalEnsuring your entire team has the necessary education and training to follow and understand oral cancer detection protocols can be crucial to effective patient care.
5 things to know about cancer prehabilitation
5 things to know about cancer prehabilitationThe dental team is in a position to make a difference to those affected by cancer. Prehabilitation is comprehensive, anticipatory care for oral issues surrounding cancer before debilitating side effects of the disease or treatment develop.
Hygienist burnout? Ways to make sure you sizzle rather than fizzle
Hygienist burnout? Ways to make sure you sizzle rather than fizzleWhat kind of career can a dental hygienist evolve to as the future of dentistry continues to corporate with our medical community? Are you ready for limitless options?
NIH awards NYU, UCLA funds to study effect of cannabinoids on cancer pain
NIH awards NYU, UCLA funds to study effect of cannabinoids on cancer painThe National Institutes of Health awarded NYU’s Bluestone Center for Clinical Research and UCLA $2.4 million to further study the use of non-psychotropic cannabinoids to suppress chronic cancer pain.